Amy Wahba

Biochemistry, Genetics and Molecular Biology · Life Sciences

26h-index1.8kcitations103works0.02yr avg

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

RNA and protein synthesis mechanisms(31), RNA modifications and cancer(20), PI3K/AKT/mTOR signaling in cancer(19), RNA Research and Splicing(12), ATP Synthase and ATPases Research(10)

Publications103 total

IP05-05 REGIONAL PROSTATE CANCER TRANSCRIPTOMIC HETEROGENEITY OBSERVED IN A COMPARATIVE ANALYSIS WITH A A NATIONAL COHORT

The Journal of Urology·2025

Figure S1 from The XPO1 Inhibitor Selinexor Inhibits Translation and Enhances the Radiosensitivity of Glioblastoma Cells Grown In Vitro and In Vivo

2023Open Access

Figure S4 from The XPO1 Inhibitor Selinexor Inhibits Translation and Enhances the Radiosensitivity of Glioblastoma Cells Grown In Vitro and In Vivo

2023Open Access

Figure S2 from The XPO1 Inhibitor Selinexor Inhibits Translation and Enhances the Radiosensitivity of Glioblastoma Cells Grown In Vitro and In Vivo

2023Open Access

Figure S3 from The XPO1 Inhibitor Selinexor Inhibits Translation and Enhances the Radiosensitivity of Glioblastoma Cells Grown In Vitro and In Vivo

2023Open Access

Figure S2 from The XPO1 Inhibitor Selinexor Inhibits Translation and Enhances the Radiosensitivity of Glioblastoma Cells Grown In Vitro and In Vivo

2023Open Access

Data from The XPO1 Inhibitor Selinexor Inhibits Translation and Enhances the Radiosensitivity of Glioblastoma Cells Grown In Vitro and In Vivo

2023Open Access

Figure S1 from The XPO1 Inhibitor Selinexor Inhibits Translation and Enhances the Radiosensitivity of Glioblastoma Cells Grown In Vitro and In Vivo

2023Open Access

Data from The XPO1 Inhibitor Selinexor Inhibits Translation and Enhances the Radiosensitivity of Glioblastoma Cells Grown In Vitro and In Vivo

2023Open Access

Figure S4 from The XPO1 Inhibitor Selinexor Inhibits Translation and Enhances the Radiosensitivity of Glioblastoma Cells Grown In Vitro and In Vivo

2023Open Access

Figure S3 from The XPO1 Inhibitor Selinexor Inhibits Translation and Enhances the Radiosensitivity of Glioblastoma Cells Grown In Vitro and In Vivo

2023Open Access

Supplementary Table 3 from The ATP-Competitive mTOR Inhibitor INK128 Enhances In Vitro and In Vivo Radiosensitivity of Pancreatic Carcinoma Cells

2023Open Access

Supplemental Tables S1-S4 from Polysome Profiling Links Translational Control to the Radioresponse of Glioblastoma Stem-like Cells

2023Open Access

Supplementary Table 1 from The ATP-Competitive mTOR Inhibitor INK128 Enhances In Vitro and In Vivo Radiosensitivity of Pancreatic Carcinoma Cells

2023Open Access

Supplementary Figure S2 from 4E-BP1 Is a Tumor Suppressor Protein Reactivated by mTOR Inhibition in Head and Neck Cancer

2023Open Access

Data from The ATP-Competitive mTOR Inhibitor INK128 Enhances In Vitro and In Vivo Radiosensitivity of Pancreatic Carcinoma Cells

2023Open Access

Data from 4E-BP1 Is a Tumor Suppressor Protein Reactivated by mTOR Inhibition in Head and Neck Cancer

2023Open Access

Supplementary Figure S6 from 4E-BP1 Is a Tumor Suppressor Protein Reactivated by mTOR Inhibition in Head and Neck Cancer

2023Open Access

Supplemental Figure S2 from Polysome Profiling Links Translational Control to the Radioresponse of Glioblastoma Stem-like Cells

2023Open Access

Supplementary Table 2 from The ATP-Competitive mTOR Inhibitor INK128 Enhances In Vitro and In Vivo Radiosensitivity of Pancreatic Carcinoma Cells

2023Open Access

page 1 of 6Next →

Frequent Co-authors

J N Dholakia(11), Philip J. Tofilon(10), Kevin Camphausen(8), Barbara H. Rath(7), Charles L. Woodley(6), S Ochoa(5), L.J. Parkhurst(5), Margarita Salas(4), Dixie J. Goss(4), Mark J. Miller(4), W. M. Stanley(3), Harshvardhan B. Mehta(3), Merrill B. Hille(3), Uma Shankavaram(3), Jonathan B. Chaires(3), Kenta Iwasaki(2), Thomas H. MacRae(2), Thomas J. Hayman(2), Heekyong Bae(2), Tamalee Kramp(2)